Drug profile · INN
cryptenamine tannates
UNITENSEN
cryptenamine tannates (UNITENSEN) is a unknown. Route of administration: oral. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — cryptenamine tannates
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
cryptenamine tannates (UNITENSEN) is a unknown. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN cryptenamine tannates
Brand UNITENSEN
Mechanism Unknown
Route ORAL
Formulation TABLET
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is cryptenamine tannates?
cryptenamine tannates (UNITENSEN) is a unknown. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for cryptenamine tannates?
UNITENSEN is a marketed brand name for cryptenamine tannates. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cryptenamine tannates?
cryptenamine tannates has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.